Kengo Watanabe Selected Research

Chronic Disease (Chronic Diseases)

11/2018	Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives.
12/2017	Discovery of DS28120313 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4,6-disubstituted indazole derivatives.
1/2017	Discovery of DS79182026: A potent orally active hepcidin production inhibitor.
1/2017	Synthesis and SAR studies of 3,6-disubstituted indazole derivatives as potent hepcidin production inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kengo Watanabe Research Topics

Disease

4	Anemia 11/2018 - 01/2017
4	Chronic Disease (Chronic Diseases) 11/2018 - 01/2017
3	Neoplasms (Cancer) 08/2019 - 11/2007
1	Neoplasm Metastasis (Metastasis) 08/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Inflammation (Inflammations) 11/2018
1	AIDS-Related Complex (ARC) 01/2018
1	Drug-Related Side Effects and Adverse Reactions 10/2010
1	Body Weight (Weight, Body) 11/2007

Drug/Important Bio-Agent (IBA)

4	HepcidinsIBA 11/2018 - 01/2017
1	Carrier Proteins (Binding Protein)IBA 08/2019
1	CrizotinibIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	lorlatinibIBA 01/2019
1	entrectinibIBA 01/2019
1	Leucine (L-Leucine)FDA Link 01/2018
1	IronIBA 12/2017
1	Carboxylic AcidsIBA 10/2010
1	GlucuronidesIBA 10/2010
1	ethylene dichloride (1,2-dichloroethane)IBA 11/2007
1	Methylene Chloride (Dichloromethane)IBA 11/2007
1	DNA (Deoxyribonucleic Acid)IBA 11/2007
1	methylene bromide (dibromomethane)IBA 11/2007

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 08/2019
1	Therapeutics 08/2019